Some reviews have summarized medicinal plants and natural products as NLRP3 inhibitors (Bagherniya et al., 2021) and natural inhibitors targeting AD and Parkinson’s disease (Lee et al., 2021); however, the inhibitors, including formulas, extracts, and single molecules, were not fully reviewed. Here, NLRP3 is linked to Alzheimer disease.